Maternofetal transmission of cytomegalovirus (CMV) is the most common infectious cause of congenital malformation in developed countries. Maternal infection often results from close contact with infected children, and this may occur in day care centres (DCCs).
Seropositivity for CMV, which identifies individuals who have acquired CMV infection, is found in 45 to >90% of women of reproductive age ranges, and varies between countries, socio-economic status, and ethnicity. 5, 6 A primary CMV infection occurs annually in approximately 1% to 2% of seronegative pregnant women. 7 However, both a primary and secondary maternal CMV infection (ie, reactivation of latent virus or re-infection with a different strain) can lead to maternofetal transmission of CMV, causing disease in the infant, and significant burden of disease worldwide. [8] [9] [10] Acquisition of CMV usually occurs via close contact with an individual excreting CMV in their body fluids, including saliva, urine, and blood. 11 In particular, saliva and urine of CMV-infected children are common sources of transmission to pregnant women. 12 CMV transmission is known to occur from young children attending a day care centre (DCC) to their siblings and parents. 13, 14 Research shows many mothers with a CMV-infected child less than 2 years of age and attending day care seroconvert within 1 year of commencement at day care, at a rate of 30% compared with 3% for those without infected children. 15 Staff at DCCs who are repeatedly exposed to CMV, many of whom are women of childbearing age, are also at risk of CMV infection. 16, 17 Despite this risk, a large proportion (61% to 87.5%) of pregnant women and providers of their clinical care are unaware and uninformed about congenital CMV infection. [18] [19] [20] [21] [22] [23] [24] [25] Given that transmission to pregnant women from infected children, including those in childcare, is a significant risk factor for CMV infection during pregnancy, it is essential to quantify this risk in order to (1) aid discussions with pregnant women about risk; (2) better define prognosis in at-risk women; (3) improve discussion with, and counselling of, pregnant women regarding prevention; and (4) inform policy discussions regarding prevention methods for congenital CMV. We systematically reviewed the prevalence of CMV infection in children attending DCCs and analysed the factors contributing to CMV infection among these children. Such data can be used to inform strategies to prevent CMV transmission to adults in childcare and allow better information for pregnant women and their carers.
| METHODS
Two reviewers independently conducted a systematic search for stud- Studies were eligible for inclusion if (1) they were case-control or uncontrolled cohort/cross sectional studies; (2) the study population was of pre-school age (defined as less than 7 years); (3) subjects attended childcare facilities that were DCCs and day nurseries; (4) the study controls had no childcare exposure; and (5) the prevalence of CMV infection was reported as either CMV excretion detected by culture or polymerase chain reaction (PCR) or seropositivity detected by the presence of CMV antibodies. For prospective studies, presence of CMV virus excretion at the end of the study was used. Studies were ineligible for inclusion if they were (1) review articles; (2) case reports; (3) letters to the editor; (4) articles not published in peer-reviewed journals; and (5) the study subjects attended non-DCC settings, including hospital nurseries and orphanages.
All studies were critically appraised using the Newcastle-Ottawa Scale (NOS). 26 Modifications were made to enhance the suitability of the NOS in different study types. The original NOS was used for case-controlled studies (Supporting Information Table S2 and Supporting Information Figure S1 ) with a total score of nine awarded to three areas of evaluation: selection, comparability, and outcome. A score of five or more was considered to represent moderate to good study quality. In the comparability category, studies were evaluated if they had controlled for age, which is the most important factor to influence CMV prevalence. For the uncontrolled studies, the same three categories of evaluation were employed, with some criteria deemed inapplicable and omitted ( Figures S2 and S3 ). As such, the prospective cohort (Supporting Information Table S3 ) and cross-sectional studies (Supporting Information Table S4 ) were evaluated relative to total scores of eight and six, respectively. A score of >50% of the maximum score was considered as moderate to good study quality.
For controlled studies, unadjusted odds ratios (OR) with 95% CI
and P values for CMV infection among DCC children versus those in the control group were calculated using Mantel-Haenszel method with random effects models. I 2 statistics and χ 2 /df were employed to determine statistical heterogeneity. Due to significant heterogeneity among studies, only results from random effects models are presented.
Pooled prevalence of CMV infection (with 95% CI) were reported separately for controlled and uncontrolled studies, and as a combined estimate. Standard error (SE) was calculated using the following formula: SE = √p(1 − p)/n; where p = prevalence and n = number of cases or controls. Analyses were performed in Review Manager (v5.3, Copenhagen, The Cochrane Collaboration).
Data were extracted on variables that are putative risk factors for CMV infection among children attending DCCs, including age, age at first DCC attendance, DCC size, close proximity, duration of DCC attendance, and breastfeeding.
| RESULTS
The primary search yielded 894 publications and abstracts. After review of titles and abstracts regarding suitability for inclusion, 27/894 studies were included, with one additional study identified from reference lists ( Figure 1 ). Of the 28 included studies, involving a total study population of 8347 children, 9/28 were case-control studies with 1824 children attending DCCs and 3477 controls (Table 1) . [27] [28] [29] [30] [31] [32] [33] [34] [35] Of these, 1/9 publications also reported two uncontrolled cross-sectional studies involving 20 and 40 subjects, respectively (Table 2) . 27 Within the remaining 19/ 28 uncontrolled studies involving 3046 subjects, 11/19 were prospective cohort studies with a study period ranging from 2 months to 4.5 years, and 8/19 were cross-sectional studies (Table 2 ).
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| Characteristics of included studies
The participating children were predominantly from developed countries, with 14/28 studies conducted in North America and 8/28 in Europe (Tables 1 and 2 Cytomegalovirus was detected using viral culture followed by observation of cytopathic effect in 24/28 of the included studies, of which most were published during or prior to 1996 (Tables 1 and 2 ).
With the exception of O'Brien et al, 34 Chomel et al, 53 Information Tables S2-S4 ). Study quality was mainly reduced by unreported non-response rate in case-control studies, inadequate follow-up in cohort studies, and absence of non-exposed cohort among cross-sectional studies.
| Prevalence of CMV infection among children attending childcare
The pooled prevalence of CMV infection among all children attending DCCs was 32% (95% CI 23%-41%). In the controlled studies, the pooled prevalence of CMV infection in children attending DCCs was 34% (95% CI 25%-44%) compared with 22% (95% CI 15-30) in the control (non-DCC) group. There was significant heterogeneity across studies (χ 2 /df = 8; I 2 = 84%). Sources of heterogeneity included Liu et al, 32 O'Brien et al, 34 and Blackman et al 31 and were attributable to differences in study recruitment methodology. In Liu et al 32 and O'Brien et al, 34 study populations were selected randomly. In the other 28 studies, randomisation was not utilised, and controls were predominantly selected from clinic or hospital populations, with the possibility of bias towards more severe disease. The effects of high heterogeneity were reduced by using the random effects model to provide more conservative effect estimates.
| Meta-analysis
3.4 | Factors contributing to higher CMV excretion rates among children attending childcare
| Age
Twelve studies explored the age-related prevalence of CMV excretion among children attending DCCs and identified viral excretion 29 and between 4 and 7 years age. 32 CMV excretion rates generally declined after 2 years age. 47 Pass et al 28 reported
that CMV excretion in a DCC increased with age, with CMV excretion found in 9% of children less than 1 year age, and 78% of children between 1 and 2 years age. The CMV excretion rate steadily declined over the following 3 years, falling to 42% by 5 years age. Hutto et al, 40 Murph et al, 41 and Pass et al 37 similarly observed maximal viral excretion (61%-83%) occurring in children between 13 and 24 months of age, and a general decrease thereafter. The prevalence of CMV excretion by age from 0 to 49+ months is outlined in Table 3 . In univariate analysis of 256 children recruited from six DCCs, every year of increase in age was associated with an 18% decrease in the risk of CMV excretion in saliva (OR 0.8, 95% CI 0.7-1.0). 35 Hutto et al 30 reported similar trends with a peak CMV excretion rate of 77% in the age group of 25 to 36 months and a third of that in those older than 48 months. Interestingly, this age-dependent variation was absent among home care children. 30 
| Enrolment age
Enrolment age refers to the age of children at first DCC attendance.
Adler et al 48 
| Duration of DCC attendance
Two studies reported an association between duration of exposure to the DCC environment and the rate of CMV excretion. 44 , 45 Volpi et al 45 found a significantly higher prevalence of CMV excretion among children who were enrolled for more than 2 years as compared with those enrolled for less than 6 months (23% versus 4%; P = 0.028).
Children excreting CMV (excretors) were also likely to spend more time per week in the DCC (41.8 ± 9.0 hours for excretor versus 36.1 ± 10.9 hours for non-excretors; P = 0.012). 44 De Mello et al 51 found no significant difference in prevalence of CMV excretion in relation to the time that children attended DCCs.
| Breastfeeding
Two studies observed that breastfeeding was related to higher CMV excretion, while one study did not find an association. There are some confounders that occur with all such reviews, and some specific to CMV in DCC, none of which significantly affect our conclusions. Generally, the meta-analyses of observational studies here were affected by confounding factors inherent in the original 30, 40 ); and (3) controls were either from hospital 29, 35 or from home/out-of-home care. 27, 28, [30] [31] [32] Potential confounders specific to DCCs include (1) differing size of DCC 30, 46 as crowding effects may outweigh hygiene practices as the determining factor for transmission, 28 and (2) differing diagnosis of CMV infection with blood PCR in 4/28 and urine or saliva excretion in 24/28 studies (Tables 1 and 2 ).
This review demonstrated the high prevalence of CMV infection in the DCCs and highlights the need to formulate effective prevention measures to minimise the risk of child-to-mother transmission. Measures shown and recommended to reduce CMV infection include not sharing food, utensils, cups, or washcloths with a child; regular handwashing; and not kissing a child on or near the mouth. [55] [56] [57] [58] [59] Until an effective treatment is available, education of day-care workers and pregnant women regarding these hygiene measures remains the best preventive strategy for congenital CMV infection and subsequently congenital CMV disease. Additional measures, including further informing women, pregnant women, childcare workers, and the general population regarding the risks of congenital CMV should be considered as further ways of reducing the risk of congenital CMV.
Given the rates of CMV infection in DCCs, it is worthwhile considering highlighting prevention recommendations in DCC for using methods such as handwashing, lack of food sharing, avoiding saliva contact, and surface cleaning. 57 Many of these are usual practice, but the specific risk of CMV could be highlighted, given known lack of knowledge about this condition, 18 and the primacy of this condition among serious congenital infections associated with infection of the pregnant mother.
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